Mono Pharmacare Key Ratios
₹8.55
₹-0.45
(-5.00%)
As on 01-Sep-2026IST
Market cap
₹15 Cr
Revenue (TTM)
₹168 Cr
P/E Ratio
42.8
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 37.60 | -- | -- |
| EBIT | -- | -- | 20.86 | -- | -- |
| Net Profit | -- | -- | 26.32 | -- | -- |
| EPS | -- | -- | 26.53 | -- | -- |
| Book Value | -- | -- | 10.99 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 4.46 | 5.08 | 5.44 |
| Net Margin
| -- | -- | 1.83 | 2.01 | 2.58 |
| Return on equity
| -- | -- | 10.47 | 11.85 | 5.24 |
| Return on Capital
| -- | -- | 11.00 | 10.22 | 3.16 |
| Return on Assets
| -- | -- | 3.25 | 3.42 | 1.12 |
| Debt to Equity (x)
| -- | -- | 1.72 | 1.47 | 3.03 |
Profitability
ROCE
11.00
Lower than Peers by 3.71
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
11.00
|
10.22
|
3.16
|
--
|
--
|
|
Peer Median
|
14.72
|
18.85
|
11.60
|
11.89
|
--
|
ROE
10.47
Lower than Peers by 1.20
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
10.47
|
11.85
|
5.24
|
--
|
--
|
|
Peer Median
|
11.67
|
14.92
|
11.46
|
13.43
|
--
|
ROA
3.25
Lower than Peers by 4.61
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
3.25
|
3.42
|
1.12
|
--
|
--
|
|
Peer Median
|
7.86
|
9.06
|
6.44
|
7.03
|
--
|
EBIT Margin
4.46
Lower than Peers by 10.57
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
4.46
|
5.08
|
5.44
|
--
|
--
|
|
Peer Median
|
15.03
|
14.71
|
12.37
|
16.50
|
--
|
Net Margin
1.83
Lower than Peers by 7.49
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.83
|
2.01
|
2.58
|
--
|
--
|
|
Peer Median
|
9.33
|
8.49
|
10.02
|
10.49
|
--
|
Cash Profit Margin
1.92
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.92
|
2.10
|
2.77
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
37.60
Higher than Peers by 27.33
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
37.60
|
353.27
|
--
|
--
|
--
|
|
Peer Median
|
10.27
|
11.85
|
9.08
|
13.45
|
--
|
EBIT Growth
20.86
Lower than Peers by 3.29
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
20.86
|
323.26
|
--
|
--
|
--
|
|
Peer Median
|
24.15
|
28.00
|
-3.12
|
18.27
|
--
|
Net Profit Growth
26.32
Lower than Peers by 3.98
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
26.32
|
250.51
|
--
|
--
|
--
|
|
Peer Median
|
30.29
|
36.51
|
-0.85
|
27.20
|
--
|
EPS Growth
26.53
Higher than Peers by 2.03
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
26.53
|
144.35
|
--
|
--
|
--
|
|
Peer Median
|
24.50
|
--
|
-6.82
|
16.28
|
--
|
Book Value Growth
10.99
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
10.99
|
110.03
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.72
Higher than Peers by 1.49
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.72
|
1.47
|
3.03
|
--
|
--
|
|
Peer Median
|
0.23
|
0.20
|
0.15
|
0.15
|
--
|
Short term debt to equity ratio
0.88
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
0.88
|
0.87
|
1.68
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.07
Higher than Peers by 0.27
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
2.07
|
2.24
|
1.96
|
--
|
--
|
|
Peer Median
|
1.79
|
1.96
|
2.08
|
1.89
|
--
|
Quick Ratio
1.02
Lower than Peers by 0.45
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.02
|
1.06
|
0.91
|
--
|
--
|
|
Peer Median
|
1.47
|
1.44
|
1.58
|
1.64
|
--
|
Interest Coverage
2.11
Lower than Peers by 7.31
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
2.11
|
2.05
|
2.21
|
--
|
--
|
|
Peer Median
|
9.42
|
8.58
|
15.41
|
15.38
|
--
|
Operating Efficiency
Debtors to sales
24.88
Lower than Peers by 0.94
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
24.88
|
25.82
|
81.03
|
--
|
--
|
|
Peer Median
|
25.82
|
26.12
|
22.96
|
20.72
|
--
|
Asset Turnover
1.76
Higher than Peers by 1.01
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.76
|
1.70
|
0.43
|
--
|
--
|
|
Peer Median
|
0.75
|
0.77
|
0.65
|
0.61
|
--
|
Receivable days
79.66
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
79.66
|
79.75
|
295.76
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
105.89
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
105.89
|
111.85
|
442.02
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
34.13
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
34.13
|
27.14
|
102.92
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
151.42
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
151.42
|
164.46
|
634.87
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
13.21
Lower than Peers by 26.50
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
13.21
|
31.90
|
--
|
--
|
--
|
|
Peer Median
|
39.70
|
33.48
|
37.74
|
60.11
|
--
|
Price / Book Value
1.31
Lower than Peers by 2.41
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
1.31
|
2.77
|
--
|
--
|
--
|
|
Peer Median
|
3.72
|
4.21
|
3.22
|
3.92
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.16
|
0.21
|
0.57
|
0.56
|
--
|
EV/EBITDA
10.87
Lower than Peers by 19.36
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
10.87
|
18.52
|
30.01
|
--
|
--
|
|
Peer Median
|
30.23
|
29.90
|
28.81
|
25.94
|
--
|
Market Cap
41
Lower than Peers by 4,810
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mono Pharmacare
|
41
|
78
|
--
|
--
|
--
|
|
Peer Median
|
4,851
|
2,099
|
15,272
|
13,501
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
